Stereotactic Surgery Devices Market Report

Market Overview:

The global stereotactic surgery devices market size reached US$ 25.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.52% during 2024-2032. The rising prevalence of chronic and acute indications requiring surgical procedures, increasing geriatric population that is more susceptible to developing neurological disorders the increasing healthcare expenditure represent some of the key factors driving the market. 

Stereotactic surgery devices are medical instruments used in a specialized neurosurgical procedure known as stereotactic surgery. These devices are designed to precisely target and treat specific areas of the anatomy with minimal damage to surrounding tissues. Stereotactic surgery is often used for the treatment of various neurological diseases, such as brain tumors, Parkinson's disease, and epilepsy. Stereotactic surgery devices utilize image-based guiding techniques to create a virtual representation of the target area which enables surgeons to accurately navigate and plan the surgical procedure. In addition to this, these devices can be integrated with other technologies, such as MRI or CT scanners, to provide real-time imaging during the procedure for enhanced accuracy and precision. As a result, these devices are extensively utilized in a variety of surgical procedures, including tumor removal, placement of electrodes for deep brain stimulation, and delivery of radiation therapy for cancer treatment.

Stereotactic Surgery Devices Market Trends:

The market is primarily driven by the rising number of surgical procedures across the globe. This can be attributed to the increasing incidences of various neurological disorders such as Parkinson's disease, epilepsy, and brain tumors. In line with this, continual technological advancements, such as the development of small incisions or needle-based surgery systems with less tissue damage, reduced scarring, and real-time monitoring capabilities is propelling the market. Moreover, the rapid product utilization in minimally invasive surgeries, radiosurgeries, and outpatient procedures due to minimal hospitalization and faster recovery is creating lucrative growth opportunities in the market. Additionally, the increasing geriatric population that is more susceptible to developing neurological disorders is also creating a positive outlook for the market. The market is further fueled by the integration of artificial intelligence (AI), robotics and 3D imaging and mapping techniques in the surgical procedures. Apart from this, the increasing healthcare expenditure on the global level is propelling the demand for high-quality medical equipment, including stereotactic surgery devices. Some of the other factors contributing to the market include the increasing number of clinical trials, implementation of favorable reimbursement policies for stereotactic surgery procedures, growing number of strategic partnerships and collaborations among key players, and extensive research and development (R&D) activities.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global stereotactic surgery devices market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type and application. 

Product Type Insights: 

• Gamma Knife
• Linear Accelerator (LINAC) Machine
• Proton Beam
• Cyberknife 
   

The report has provided a detailed breakup and analysis of the stereotactic surgery devices market based on the product type. This includes gamma knife, linear accelerator (LINAC) machine, proton beam, and cyberknife. According to the report, linear accelerator (LINAC) machine represented the largest segment. 

Application Insights: 

• Brain Tumor Treatment
• Arteriovenous Malformations Treatment
• Parkinson’s Disease
• Epilepsy
• Trigeminal Neuralgia 
   

A detailed breakup and analysis of the stereotactic surgery devices market based on the application has also been provided in the report. This includes brain tumor treatment, arteriovenous malformations treatment, Parkinson’s disease, epilepsy, and trigeminal neuralgia.

Regional Insights: 

• North America 
  • United States 
  • Canada 
• Europe 
  • Germany 
  • France 
  • United Kingdom 
  • Italy 
  • Spain
  • Others 
• Asia Pacific 
  • China 
  • Japan 
  • India 
  • South Korea 
  • Australia 
  • Indonesia 
  • Others 
• Latin America 
  • Brazil 
  • Mexico 
  • Others 
• Middle East and Africa
   

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for stereotactic surgery devices. Some of the factors driving the North America stereotactic surgery devices market included the aging population, technological advancements, high healthcare expenditure, etc. 

Competitive Landscape: 

The report has also provided a comprehensive analysis of the competitive landscape in the global stereotactic surgery devices market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Accuray Incorporated, Elekta, Hitachi Ltd., Mevion Medical Systems, Shinva Medical Instrument Co. Ltd, Varian Medical Systems Inc. (Siemens Healthineers), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report. 

Stereotactic Surgery Devices Market Report Scope:

Key Questions Answered in This Report: 

• How has the global stereotactic surgery devices market performed so far, and how will it perform in the coming years? 
• What are the drivers, restraints, and opportunities in the global stereotactic surgery devices market? 
• What is the impact of each driver, restraint, and opportunity on the global stereotactic surgery devices market? 
• What are the key regional markets? 
• Which countries represent the most attractive stereotactic surgery devices market? 
• What is the breakup of the market based on the product type? 
• Which is the most attractive product type in the stereotactic surgery devices market? 
• What is the breakup of the market based on the application? 
• Which is the most attractive application in the stereotactic surgery devices market? 
• What is the competitive structure of the global stereotactic surgery devices market? 
• Who are the key players/companies in the global stereotactic surgery devices market? 

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the stereotactic surgery devices market from 2018-2032.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global stereotactic surgery devices market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region. 
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the stereotactic surgery devices industry and its attractiveness. 
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.